Tak Mao Chan (T M Chan)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Angiotensin Converting Enzyme

Methicillin Resistant Staphylococcus Aureus

Rheumatoid Arthritis Patients

Top Venues

Nephrology (Carlton, Vic.)

Expert review of clinical immunology

Clinical journal of the American Society of Nephrology : CJASN

This page only lists publications with an associated author ORCID identifier.

Publications

Desmond Yat-Hin Yap, Ronald C W Ma, Emmanuel C K Wong, Matthew S H Tsui, Esther Y T Yu, Vivien Yu, Cheuk-Chun Szeto, Wing Fai Pang, Hung Fat Tse, David C W Siu, Kathryn C B Tan, Walter W C Chen, Chiu Leong Li, Wei Chen, Tak Mao Chan
Consensus statement on the management of hyperkalaemia-An Asia-Pacific perspective. Nephrology (Carlton, Vic.) 29 (6) (2024)
Desmond Yat-Hin Yap, Ronald C W Ma, Emmanuel C K Wong, Matthew S H Tsui, Esther Y T Yu, Vivien Yu, Cheuk-Chun Szeto, Wing Fai Pang, Hung Fat Tse, David C W Siu, Kathryn C B Tan, Walter W C Chen, Chiu Leong Li, Wei Chen, Tak Mao Chan
Consensus statement on the management of hyperkalaemia-An Asia-Pacific perspective. Nephrology (Carlton, Vic.) (2024)
Juan Manuel Mejia Vilet, Zhi-Hong Liu, Tak Mao Chan
Choosing the Right Treatment in Patients with Lupus Nephritis. Clinical journal of the American Society of Nephrology : CJASN (2022)
Desmond Y H Yap, Tak Mao Chan
What is the ideal duration of maintenance therapy for lupus nephritis? Expert review of clinical immunology 18 (5) (2022)
Maggie M Y Mok, Lorraine P Y Kwan, Gary C W Chan, Maggie K M Ma, Angela Y M Wang, Desmond Y H Yap, Cindy B Y Choy, Sydney Chi-Wai Tang, Tak Mao Chan
Conversion from Aranesp® to NESP® in dialysis patients-Exploration of dosing strategies and the feasibility of extending the dosing interval. Nephrology (Carlton, Vic.) 26 (9) (2021)
Eugene Yu Hin Chan, Desmond Yat Hin Yap, Wilfred Hing Sang Wong, Tsz Wai Ho, Pak Chiu Tong, Wai Ming Lai, Tak Mao Chan, Alison Lap Tak Ma
Demographics and long-term outcomes of children with end-stage kidney disease: A 20-year territory-wide study. Nephrology (Carlton, Vic.) (2021)
Kelvin Yc Yu, Susan Yung, Mel Km Chau, Colin So Tang, Desmond Yh Yap, Alexander Hn Tang, Shirley Ky Ying, Cheuk Kwong Lee, Tak Mao Chan
Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis. Lupus 30 (7) (2021)
Carlos King-Ho Wong, Julie Yun Chen, Samuel K S Fung, Maggie Mok, Yuk Lun Cheng, Irene Kong, Wai Kei Lo, Sing Leung Lui, Tak Mao Chan, Cindy Lo Kuen Lam
Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy. BMC nephrology 21 (1) (2020)
Susan Yung, Desmond Yh Yap, Tak Mao Chan
A review of advances in the understanding of lupus nephritis pathogenesis as a basis for emerging therapies. F1000Research 9 (2020)
Chenzhu Zhang, Caleb C Y Chan, Kwok Fan Cheung, Mel K M Chau, Desmond Y H Yap, Maggie K M Ma, Kwok Wah Chan, Susan Yung, Tak Mao Chan
Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis. Clinical science (London, England : 1979) 133 (15) (2019)
Carlos King-Ho Wong, Julie Yun Chen, Samuel K S Fung, Wai Kei Lo, Sing Leung Lui, Tak Mao Chan, Yuk Lun Cheng, Irene Kong, Eric Yuk Fai Wan, Cindy L K Lam
Health-related quality of life and health utility of Chinese patients undergoing nocturnal home haemodialysis in comparison with other modes of dialysis. Nephrology (Carlton, Vic.) 24 (6) (2019)
Lorraine Py Kwan, Maggie My Mok, Bo Ying Choy, Tak Mao Chan
Acute kidney injury in a renal transplant recipient due to concomitant use of vancomycin and foscarnet. Nephrology (Carlton, Vic.) 22 (10) (2018)
Susan Yung, Desmond Yh Yap, Tak Mao Chan
Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis. F1000Research 6 (2017)